Evidence map›Paper›PMID 38148364›Full record

ArticleMedical oncology (Northwood, London, England)2023

GNL3L promotes autophagy via regulating AMPK signaling in esophageal cancer cells.

Weiting He, Fengyao Sun, Wen Li, Ruihang Du, Siyuan Yan, Changqing Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Anti-inflammatory and protective effects ofFrontiers in pharmacology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Weiting HeSchool of Clinical Medicine, Bengbu Medical College, Bengbu, 233030, China.
Fengyao SunInstitute of Precision Medicine, Precision Medicine Laboratory for Chronic Non-Communicable Diseases of Shandong Province, Jining Medical University, Jining, 272067, China.
Wen LiInstitute of Precision Medicine, Precision Medicine Laboratory for Chronic Non-Communicable Diseases of Shandong Province, Jining Medical University, Jining, 272067, China.
Ruihang DuInstitute of Precision Medicine, Precision Medicine Laboratory for Chronic Non-Communicable Diseases of Shandong Province, Jining Medical University, Jining, 272067, China.
Siyuan YanInstitute of Precision Medicine, Precision Medicine Laboratory for Chronic Non-Communicable Diseases of Shandong Province, Jining Medical University, Jining, 272067, China. yansy@mail.jnmc.edu.cn.ORCID http://orcid.org/0000-0002-4127-904X
Changqing LiuSchool of Clinical Medicine, Bengbu Medical College, Bengbu, 233030, China. lcq7813@bbmc.edu.cn.
Jining Medical University · CNBengbu Medical College · CN

Funding

Natural Science Foundation of Shandong Province ZR2023MH329Science Research Project of Bengbu Medical College 2021byfy002
6 · The paper itself

Abstract

Guanine nucleotide-binding protein-like 3-like (GNL3L), a conserved GTP-binding nucleolar protein, participates in regulating cell proliferation, and associates with tumorigenesis and poor prognosis in several kind of cancers. However, the role of GNL3L in modulating autophagy remains unclear. Here, we verified that GNL3L was higher expressed in esophageal cancer (ESCA) biopsies than that in the corresponding normal biopsies by a human ESCA tissue array. Utilizing immunoblotting and real-time PCR assays, we analyzed the expression of GNL3L in several ESCA cell lines, and it was highly expressed in KYSE410 cells and rarely expressed in KYSE150 cells, respectively. GNL3L overexpression promoted cell viability and cell proliferation in KYSE150 cells. On the contrary, silencing of GNL3L resulted in opposite phenotypes in KYSE410 cells. Furthermore, GNL3L level correlated with autophagic flux and influenced the levels of autophagy core proteins. Meanwhile, GNL3L also affected the AMPK signaling pathway, which is a pivotal signaling pathway for autophagy regulation. In the GNL3L-silenced cells, the AMPK agonist AICAR partly rescued the autophagic flux. Inversely, both pharmacologically and genetically deprivation of AMPK attenuated the autophagic flux induced by GNL3L overexpression. Moreover, AMPK activity alteration influenced the effect of GNL3L in regulating cell proliferation. Collectively, these findings suggest that GNL3L positively regulates cell proliferation and autophagy in ESCA cells via regulating the AMPK signaling, making itself a promising therapeutic target for ESCA.

Indexed as

AMP-Activated Protein KinasesEsophageal NeoplasmsAutophagyCell Line, TumorGTP-Binding ProteinsHumansNuclear ProteinsSignal TransductionAMP-Activated Protein KinasesGNL3L protein, humanGTP-Binding ProteinsNuclear ProteinsAMPK signalingAutophagyEsophageal cancerGNL3LProliferation

Identifiers

PMID38148364
OpenAlexW4390225616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.